Klassen was most recently Executive Vice President, Head of Global Development at Orexigen Therapeutics. He previously held several positions at Amgen, Inc, including Therapeutic Area Head for Nephrology. Before that, Klassen was a faculty member in the Division of Nephrology at Duke University Medical Center. He received his M.D. from the University Of Nebraska College Of Medicine and M.H.S. degree from Duke University.